PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that the financial results for its fiscal first quarter ended June 30, 2008, will be released after the U.S. market closes on August 5, 2008. The earnings release will be followed by a conference call at 1:30 p.m. PT (4:30 p.m. ET) on August 5, 2008, to discuss fiscal first quarter results and provide a corporate update to the investment community.
